RxDoctor Payments Data

Ravindra Chand, MD

Psychiatry · Irvine, CANPI 1013099951

Payments from drug & device makers

$978in general payments, 2019–2025

Across 56 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$852
  • Neurocrine Biosciences, Inc.$38
  • Teva Pharmaceuticals USA, Inc.$26
  • Sunovion Pharmaceuticals Inc.$22
  • Johnson & Johnson$21
  • E.r. Squibb & Sons, L.L.C.$19

What the payments were for

  • Food & beverage$978100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$978 in reported general payments places this provider in the 75th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$17,044
Medicare patients
70
Services billed
126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate85$293,087
Invega TrinzaPaliperidone Palmitate17$184,089
Abilify MaintenaAripiprazole21$59,235
LybalviOlanzapine/Samidorphan Malate24$38,411
Clozapine OdtClozapine16$6,987
Quetiapine Fumarate191$3,941
Chlorpromazine Hcl26$3,928
Divalproex Sodium108$3,388
Fluphenazine Hcl11$2,643
Olanzapine125$2,095
Clozapine35$2,081
Olanzapine OdtOlanzapine17$1,917
Divalproex Sodium ErDivalproex Sodium36$1,296
Atomoxetine Hcl12$1,083
Perphenazine25$998

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza$21$477,176102 claims
Alkermes, Inc.Lybalvi$852$38,41124 claims
Teva Pharmaceuticals USA, Inc.Loxapine$26$75317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Irvine

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →